Momenta Pharmaceuticals, Inc.
MNTA
MNTA was delisted on the 30th of September, 2020.
162 hedge funds and large institutions have $1.41B invested in Momenta Pharmaceuticals, Inc. in 2015 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 80 increasing their positions, 31 reducing their positions, and 21 closing their positions.
158% more repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 31
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
90% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 21
82% more capital invested
Capital invested by funds: $771M → $1.41B (+$635M)
40% more call options, than puts
Call options by funds: $4.55M | Put options by funds: $3.24M
13% more funds holding
Funds holding: 143 → 162 (+19)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$63M |
| 2 |
VAM
Visium Asset Management
New York
|
+$55M |
| 3 |
DCM
Discovery Capital Management
South Norwalk,
Connecticut
|
+$23.8M |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$20.7M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$20.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$29M |
| 2 |
SAM
Senzar Asset Management
New York
|
-$10.6M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$8.64M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$7.74M |
| 5 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$7.6M |
MNTA Hedge Fund Activity: Q2 2015 in Review
162 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Momenta Pharmaceuticals, Inc. (MNTA) for Q2 2015, worth a combined $1.41B — up 82% from $771M a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new MNTA positions and 21 closed out — a net gain of 19 holders — while 80 added to existing stakes and 31 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $63M. The largest seller was Sectoral Asset Management, cutting an estimated $29M.
- 162 institutional investors held Momenta Pharmaceuticals, Inc. (MNTA) as of Q2 2015, up from 143 in Q1 2015.
- Funds reported $1.41B of Momenta Pharmaceuticals, Inc. stock for Q2 2015, up 82% quarter-over-quarter.
- 40 funds opened new Momenta Pharmaceuticals, Inc. positions in Q2 2015 and 21 closed out, a net change of +19 holders.
- The largest Momenta Pharmaceuticals, Inc. buyer in Q2 2015 was Fidelity Investments, an estimated $63M added.
- The largest Momenta Pharmaceuticals, Inc. seller in Q2 2015 was Sectoral Asset Management, an estimated $29M sold.
Based on aggregated 13F filings for Q2 2015.